UPDATE: Morgan Stanley Initiates Coverage On Myriad Genetics As Survey Points To Greater Share Loss
November 10, 2014 at 09:15 AM EST
In a report published Monday, Morgan Stanley analyst Steve Beuchaw initiated coverage on Myriad Genetics, Inc. (NASDAQ: MYGN) with an ...
